Dr Anna Kalff
Dr Anna Kalff is a clinical and laboratory haematologist. She has continued as a member of the Myeloma Research Group after completing her fellowship at The Alfred and has recently been awarded her PhD, investigating novel therapies for patients with newly diagnosed and relapsed myeloma. She has published her research in peer reviewed journals and is an investigator for several myeloma related clinical trials. She attends the Clinical Haematology, Plasma Cell Disorders and Clinical Trials (myeloma) outpatient clinics, undertakes Clinical Haematology ward service as well as reporting in the Haematology Pathology lab.
Dr Kalff is a member of the Myeloma Australia Medical Scientific Advisory Group (MSAG) and Australian Myeloma Research Consortium (AMaRC) Research and Advisory Committee, and is a member of HSANZ, ALLG, IMS, ASH and EHA.